Description
February 19, 2025 | 12:00-1:00 PM
Description:
This workshop provides a framework for psychopharmacologic practice with individuals with co-occurring psychiatric and substance use disorders in accordance with nationally accepted practice guidelines. The workshop begins by reviewing a general framework for integrated treatment of individuals with co-occurring disorders based on research derived principles of successful treatment intervention within an integrated recovery approach that makes sense from the perspective of both mental health and addiction practitioners.
The workshop illustrates briefly how these principles guide both individualized assessment and individualized treatment matching for individuals with co-occurring disorders and describes a systematic process of clinical assessment – the Integrated Longitudinal Strength Based Assessment – that can be utilized in making psychopharmacologic assessments and interventions for these individuals, including those who may be actively using.
Then, based on the principles of successful treatment intervention, most of the workshop will describe systematic practice guidelines for psychopharmacologic intervention with individuals with co-occurring disorders, including both general strategies, as well as strategies for treating various diagnoses. The workshop will include attention to medication strategies and specific medications for various psychiatric conditions in individuals with co-occurring substance use disorders, including those who might be actively using. The workshop will also cover utilization of anti-craving agents and other SUD medication treatment strategies for individuals who might have co-occurring psychiatric conditions. Finally, the workshop will briefly cover approaches for dealing with challenges related to individuals who are on benzodiazepines or on opioids for chronic pain.
Learning Objectives:
- To become familiar with the six principles of successful treatment for individuals with co-occurring disorders, and their application to psychopharmacology
- To understand how to perform integrated longitudinal strength-based assessments to establish diagnoses and treatment strategies for individuals with co-occurring disorders who might be actively or recently using substances.
- To be able to apply evidence-based strategies for psychopharmacologic practice for individuals with various combinations of psychiatric and substance disorders
- To develop a basic strategy of how to use anti-craving agents and other medication treatment strategies for SUD in individuals with co-occurring disorders.
- To have a framework for how to work effectively with individuals with co-occurring conditions who are on benzodiazepines or opioids, or who are requesting such medications
Presenters:
Kenneth Minkoff, MD
Dr. Minkoff is Vice President and Chief Operating Officer Senior at ZiaPartners, Inc., a behavioral health system consultation firm in Tucson, AZ. He is Board-Certified as an addiction psychiatrist and community psychiatrist, Board Member and Products and Services Committee Chair of the American Association for Community Psychiatry, playing a leading role in the development and dissemination of the LOCUS Family of Tools, as well as the Self-assessment for Modification of Anti-Racism Tool (SMART) for which he is co-author. He was one of the original members of the federal Interdepartmental Serious Mental Illness Coordinating Committee (2017-20). He is Co-Chair of the Community Psychiatry Committee of the Group for Advancement of Psychiatry, and one of the lead authors of the 2021 Report: Roadmap to the Ideal Crisis System, published by the National Council for Mental Wellbeing. He is a member of the National Council’s Medical Director Institute and consults to the National Council Centers of Excellence on Integrated Care and CCBHCs.
Audience:
Prescribing Clinicians and their teams
Continuing Medical Education:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Hanley Center for Health Leadership and Education and CCSME. The Hanley Center for Health Leadership and Education is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Hanley Center for Health Leadership and Education designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit ™.
Contact Hours
1 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals.
1 Category 1 Contact hours for psychologists. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1 contact hours for Alcohol and Drug Counselors pending approval by the Maine Board of Alcohol and Drug Counselors
1 contract hours CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission of Health Education Credentialing, Inc.
